Phase 2 Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with an autoimmune disease that has affected your vision (such as reduced vision or damage to the back of the eye).
- You are between 18 and 60 years old.
- You are willing and able to sign a consent form and attend all required follow-up visits.
Who may not be able to join:
- You are allergic to minocycline or a group of antibiotics called tetracyclines.
- You do not have any medical reasons that would prevent you from taking minocycline or tetracyclines (confirm with trial site, as this criterion appears to describe a separate check your doctor would carry out).
- You have problems with how your liver, heart, kidneys, or thyroid are working.
- You are currently taking steroid medicines (such as prednisone), medicines that suppress the immune system, or biologic medicines.
- You are pregnant, breastfeeding, or planning to become pregnant.
- You are currently taking any other medicines for other health conditions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dan Liang, Zhongshan Ophthalmic Center, Sun Yat-sen University
Phone: （86）-87330402
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of macular sensitivity; Change of BCVA; Change of Visual field; Changes in Implicit Time and Amplitude of Photopic and Scotopic Responses
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.